62232-88-6

Basic information

• Product Name: Benzenedecanal
• Synonyms: Benzenedecanal;10-phenyl-decanal
• CAS NO: 62232-88-6
• Molecular Formula: C16H24O
• Molecular Weight: 232.366
• Mol File: 62232-88-6.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Benzenedecanal(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenedecanal(62232-88-6)
• EPA Substance Registry System: Benzenedecanal(62232-88-6)

Safety Data

• Hazardous Substances Data: 62232-88-6(Hazardous Substances Data)

Upstream product

• 53210-25-6 undec-10-en-1-ylbenzene 
• 81965-50-6 10-(tetrahydropyran-2'-yloxy)decanal 
• 112-47-0 1,10-Decanediol 
• 43047-93-4 10-tetrahydropyranyloxydecanol 
• 106484-82-6 1-Phenyl-10-(tetrahydro-pyran-2-yloxy)-decan-1-ol 
• 62607-69-6 10-phenyl-1-decanol 

Downstream Products

• 1567395-17-8 (R)-4-methyl-N-(13-phenyltridec-1-yn-4-yl)benzenesulfonamide 
• 177706-83-1 (R)-2-(9-phenylnonyl)pyrrolidine 
• 1567395-51-0 (R)-2-(9-phenylnonyl)-1-tosylpyrrolidine 
• 1567395-53-2 (R)-5-(9-phenylnonyl)-1-tosylpyrrolidin-3-one 
• 1567395-32-7 C₂₃H₃₇NOS 
• 106484-87-1 2-Methoxy-6-(10-phenyl-decyl)-phenol 
• 95690-70-3 3-(10'-phenyldecyl)benzene-1,2-diol 
• 106484-85-9 1-(3-Methoxy-2-methoxymethoxy-phenyl)-10-phenyl-decan-1-ol 
• 260050-38-2 5-(9-phenyl-nonyl)-4-tosyl-2-oxazoline 

Relevant articles and documents

Synthesis and preliminary pharmacological evaluation of 4′-arylalkyl analogues of clozapine. II. Effect of the nature and length of the linker

We report the synthesis of a second generation of tricyclic analogues of clozapine, investigating the length and nature of the chain between an ionizable nitrogen atom at physiological pH and the introduced aryl moiety. The chemistry, structural characterization, and pharmacological evaluation of this series of 4′-arylalkyl analogues of clozapine are described. Preliminary findings on the effects on activity of the nature and length of the linker, degree of unsaturation, and type of aryl moiety on blockade of dopamine D4 and serotonin 5-HT2A receptors are discussed and animal behavioural data for key compounds presented.

HYDROXY-, ALKOXY- AND BENZYLOXY-SUBSTITUTED PHOSPHOLIPIDS

Novel hydroxy-,alkoxy- and benzyloxy-substituted Novel hydroxy phospholipids, a process for the preparation thereof, and methods for treating pain, phospholipase, A2 mediated inflammation and similar conditions utilizing compounds or compositions thereof